RxDoctor Payments Data

Osaigiakpe Ugheighele

Nurse Practitioner · Riverside, CANPI 1770268740

Payments from drug & device makers

$2,958in general payments, 2019–2025

Across 123 payments — averaging $24.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$274
  • Merck$263
  • Novartis$246
  • AstraZeneca$238
  • Eisai Inc.$212
  • Sobi, Inc$183
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$2,78994%
  • Education$1696%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,958 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$17,777
Anastrozole56$1,248
Imatinib Mesylate11$825
Letrozole20$521
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$330
Prochlorperazine Maleate23$322
Gabapentin23$296
Atorvastatin Calcium28$243
Dexamethasone17$242
Potassium Chloride15$194
Acyclovir15$176
Ondansetron Hcl29$165
Alendronate Sodium11$150
Levothyroxine Sodium14$119
Furosemide12$54

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$32$17,77717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →